• 1. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Recent Advances in the Study of Benzoic Acid, 2,2'-Iminobis-, Dimethyl Ester (CAS: 34069-89-1)

Benzoic acid, 2,2'-iminobis-, dimethyl ester (CAS: 34069-89-1), a compound of significant interest in the field of chemical biology and pharmaceutical research, has recently been the subject of several groundbreaking studies. This compound, known for its unique structural properties and potential applications, has been investigated for its role in drug development, chemical synthesis, and biological activity modulation. The following sections provide a comprehensive overview of the latest research findings, methodologies, and implications associated with this compound.

Recent studies have highlighted the compound's potential as a key intermediate in the synthesis of novel pharmaceutical agents. Researchers have explored its utility in the development of antimicrobial and anti-inflammatory drugs, leveraging its structural versatility to enhance drug efficacy and reduce side effects. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to characterize its molecular interactions and stability under various conditions.

In addition to its synthetic applications, Benzoic acid, 2,2'-iminobis-, dimethyl ester has been studied for its biological activity. Preliminary in vitro assays have demonstrated its ability to modulate specific enzymatic pathways, suggesting potential therapeutic applications in metabolic disorders. These findings are supported by molecular docking studies, which reveal high-affinity binding to target proteins involved in key metabolic processes.

Further investigations into the compound's pharmacokinetics and toxicity profile have provided valuable insights into its safety and efficacy. Recent toxicological studies indicate a favorable safety profile at therapeutic doses, with minimal off-target effects. These results pave the way for future preclinical and clinical trials, positioning the compound as a promising candidate for further development.

The integration of computational modeling and experimental data has significantly advanced our understanding of this compound. Researchers have utilized quantum chemical calculations and molecular dynamics simulations to predict its behavior in biological systems, offering a robust framework for optimizing its pharmacological properties. These interdisciplinary approaches underscore the compound's potential to bridge gaps between chemical synthesis and therapeutic application.

In conclusion, the latest research on Benzoic acid, 2,2'-iminobis-, dimethyl ester (CAS: 34069-89-1) underscores its multifaceted role in pharmaceutical and chemical biology. Its structural versatility, biological activity, and favorable safety profile make it a compelling subject for ongoing and future studies. As research continues to unfold, this compound is poised to contribute significantly to the development of next-generation therapeutics and chemical innovations.

• 85-91-6(Methyl N-methylanthranilate)
• 41270-80-8(Methyl N-formylanthranilate)
• 35472-56-1(Ethyl 2-(methylamino)benzoate)
• 55426-74-9(Ethyl 2-(dimethylamino)benzoate)
• 10072-05-6(Methyl 2-(dimethylamino)benzoate)
• 35708-19-1(2-Anilinobenzoic acid methyl ester)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)